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Hematopoietic stem cells (HSCs) can differentiate into several types of hematopoietic cells (HCs)
(such as erythrocytes, megakaryocytes, lymphocytes, neutrophils, or macrophages) and also
undergo self-renewal to sustain hematopoiesis throughout an organism’s lifetime. HSCs are
currently used clinically as transplantation therapy in regenerative medicine and are typically ob-
tained from healthy donors or cord blood. However, problems remain in HSC transplantation,
such as shortage of cells, donor risks, rejection, and graft-versus-host disease (GVHD). Thus, in-
creased understanding of HSC regulation should enable us to improve HSC therapy and develop
novel regenerative medicine techniques.HSC regulation is governed by two types of activity: intrin-
sic regulation, programmed primarily by cell autonomous gene expression, and extrinsic factors,
which originate from so-called “niche cells” surrounding HSCs. Here, we focus on the latter and
discuss HSC regulation with special emphasis on the role played by niche cells.
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1. INTRODUCTION
After gastrulation,three germlayersemerge: endoderm,mesoderm,andectoderm.Amongthem, mesoderm
is the ancestor of hematopoietic cells (HCs), and both extraembryonic and intraembryonic mesoderm
contribute to HC generation. In the mouse, the site of blood cell production changes as embryos develop
over an approximately 20-day gestation period (Figure 1(a)). Hematopoiesis begins in the yolk sac (YS),
producingmainlyprimitive erythroidcellsat7.5dayspostcoitum(dpc).Shortlythereafter,deﬁnitivemyelo-
erythroid progenitor cells appear in the YS (around 8.25dpc), which then seed the fetal liver (FL). This
process, termed primitive hematopoiesis, diminishes at 12.5dpc, when deﬁnitive hematopoiesis, which
sustains the adult blood system through HSCs, begins in the FL. Although there is controversy over where
HSCs are generated—in the extraembryonic mesoderm at the YS or in the intraembryonic para-aortic-
splanchnopleural mesoderm (P-Sp)/aorta-gonad-mesonephros (AGM) region—recent studies suggest that
both regions contain HSCs capable of reconstituting adult bone marrow hematopoiesis (Figures 1(a) and
1(b)). In addition, HSCs are generated in the placenta (PL), likely independent of the YS and P-Sp/AGM
regions. Thereafter, these HSCs are thought to circulate and colonize the FL, where HSC expansionoccurs.
HSCs then temporarily reside in fetal spleen and ﬁnally shift to fetal bone marrow (BM) [1] (Figures 1(a)
and 1(b)).
2. THE YOLK SAC
The YS is a bilaminar membranous sac encasing the embryo proper. It is here the “blood islands,” the ﬁrst
site of hematopoiesis. The YS is composed of two distinct layers of cells, the visceral endoderm which
is predominantly an absorptive epithelium transporting nutrients to the embryo and the extraembryonic
mesoderm which gives rise to the endothelium of the YS and the blood cells that ﬁll these early vessels
[2]. Developing mesoderm cells can be programmed either by the visceral endoderm or by soluble factors
produced by the visceral endoderm such as Indian hedgehog (Ihh) to become hematopoietic or vascular
cells [3, 4]( Figure 2). The extraembryonicmesoderm gives rise to the ﬁrst hematopoietic cells in the devel-
oping conceptus.These include the primitive erythroid cells, macrophages,and megakaryocytesand appear
shortly after gastrulation [5]. The primitive erythroid (EryP) cells are larger than their adult-type deﬁnitive
counterparts (EryD) and express a unique set of embryonic globin genes [6]. EryP dominate the mid-ges-
tation circulation of the mouse embryo and number in the several millions; however, by birth, they will be
greatly reduced in frequency, diluted by the vast numbers of EryD generated in the FL [7, 8].
The niche supporting early hematopoietic development in the YS is poorly deﬁned. However,
recently some players in this ﬁeld have been identiﬁed. YS endothelial cells and the visceral endoderm
expressthe soluble growth factor angiopoietin 1, whereas early EryP cells expressthe angiopoietin receptor
Tie-2. Interestingly, the EryP cells themselves express soluble growth factors [9]. TGFb1 expression was
detected in the visceral endoderm and the EryP, suggesting that the developing hematopoietic cells may
be generating a unique niche themselves. The hypoxic nature of the developing YS is also supportive of
hematopoiesis [9, 10]. As the YS develops, a broad range of hematopoietic progenitors are generated.
These include deﬁnitive erythroid progenitors, myeloid progenitors, and lymphoid progenitors [5, 11, 12].
The migration of hematopoietic progenitors throughout the developing embryo has been investigated
capitalizing on knockout mouse strains lacking a heartbeat and subsequent blood ﬂow. These mice lacked
the sodium/calcium exchanger Ncx1, failed to develop a heartbeat, and subsequently hematopoietic
progenitors remained lodged at their sites of origin, namely, the YS [13] and the placenta [14]. Whether
the progenitors isolated in the Ncx-1 knockout placenta are truly HSC is yet to be resolved [14]. Shortly
before mid-gestation in the mouse embryo, long-term reconstituting HSCs appear in the YS [15]. These
cells show signiﬁcant differences compared to the HSCs generated within the embryo; however, they are
capable of giving rise to the hematopoietic system of newborn mice [15, 16]. The origin of HSC has proven
a contentious issue; however, the development of genetic models to monitor HSC sites of production has
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FIGURE 1: Schema of hematopoietic development during mouse embryogenesis. (a) The site of blood cell
production changes as embryos develop over an approximately 20-day gestation period in mice. Abbre-
viations: dpc (day post coitum), YS (yolk sac), BI (blood island), AGM (aorta-gonad-mesonephros), PL
(placenta), FL (fetal liver), BM (bone marrow), HSC (hematopoietic stem cell). (b) Corresponding to the
time course shown in (a), HSCs emerge in the YS, AGM region, and PL from early to mid-gestation (7.0–
11.0dpc). HSCs proliferate in the FL at mid-gestation and then home to fetal spleen temporarily and to fetal
BM at late gestation.
supported the YS as, at least one, source of HSC during embryogenesis. Genetic “tagging and tracing” of
early hematopoietic progenitors expressing the transcriptional regulator Runx1 in the YS suggests that this
may indeed be a site of HSC production during embryogenesis [17].
3. THE AGM REGION
After YS hematopoiesis, HSC activity is detected in the p-Sp/AGM region, where cell aggregates, termed
HC clusters or intra-aortic/arterial clusters (IACs), are observed. HSCs in the AGM region express c-
Kit/CD117 (the receptor for stem cell factor), CD31/PECAM-1 (platelet/endothelial cell adhesionmolecule
1), and CD34 (a transmembrane glycoprotein). Presumptive pre-HSCs expressing c-Kit and capable of
reconstituting neonatal recipients are detected in the p-Sp/AGM region at 9.5dpc, whereas functional c-
Kit-expressing HSCs capable of reconstituting adult recipients are ﬁrst identiﬁed in the AGM region at
10.5dpc. Special microenvironments likely enable pre-HSCs from the p-Sp/AGM region at 9.5dpc to
acquire functional HSC activity by 10.5dpc. In the AGM region, IACs are frequently observed attached
to ﬂoors and walls of large arteries, suggesting that they are generated from EC layers (Figure 3(a)).
Mouse IACs have been characterized morphologically and are primarily located in the dorsal aorta, the
omphalomesenteric artery, and the umbilical artery. Intrinsic regulation of AGM HSCs has been well
characterized. The transmembrane receptor encoded by Notch1 is essential to generate HSCs from ECs
[18], and the ubiquitin ligase Mind bomb-1 (encoded by Mib1), which regulates Notch ligands,is important
for intraembryonic hematopoiesis not only in aortic ECs but in subaortic patches [19]. Runx1 appears to
be required for formation of intra-aortic HC clusters from ECs [20]. Several reports suggest that extrinsic
regulation of AGM HSCs is also important. Thrombopoietin (TPO)/Mpl (TPO receptor) signaling plays a
role in transition from hemogenicECs to hematopoietic progenitor cells (HPCs)/HSCs via Runx1 activation
and in production of HPCs/HSCs via Meis1 and Homeobox (Hox) b4 activation from 10.0dpc to 10.5dpc
in AGM region [21]. Intereukin-1 (IL-1) reportedly functions as an important homeostatic regulator at
1772TheScientiﬁcWorldJOURNAL (2011) 11, 1770–1780
7.5 dpc
8.5 dpc
Mesodermal cells
Endoderm
Mesoderm
Primitive RBCs
Macrophages Mesenchymal cells (MCs)
7.5 dpc
Endothelial cells
BI
YS (Flk1+)
IHH↑↑ BMP4
(ECs)(CD31+/Lyve-1+)
FIGURE 2: Hematopoietic environment in the YS. Mesodermal cells, the ancestors of hematopoietic cells,
differentiate into both hematopoietic cells within blood islands and endothelial cells (ECs) outside of that
region. Blood vessels, consisting of endothelial cells and containing primitive erythrocytes and macropha-
ges, are located among cells originating from endodermal and mesodermal cells.
earliest stages of HSC development, limiting differentiation of some HSCs along the myeloid lineage [22]
(Figure 3(b)). However, it remains unclear which factors regulate AGM HSCs. Since the AGM region
consists of ECs, gonad cells, mesonephros cells, and unclassiﬁed MCs, those cells likely comprise a
niche for HSC generation. c-Kit−/CD34− MCs of the AGM region reportedly express hedgehog recep-
tor/transducer genes, namely, Ptch1, Ptch2, and Smo, as well as genes encoding their downstream ef-
fectors, Gli1, Gli2, and Gli3, which act to increase the number of HSCs at 10.5dpc. In addition, ECs
(CD31+/CD34+/Kit−) of the AGM region at 10.5dpc likely function in HSC regulation through stem
cell factor (SCF) secretion [23]. Taken together, the niche is comprised of several factors governing HSC
generation.
4. THE PLACENTA
The PL is a highly vascularized structure that functions not only in gas exchange and fetal nutrition but in
hematopoiesis at 8.5–13.5dpc [24]. Similar to the AGM region, c-Kit-positive HC clusters in the PL are
observed in the vitelline and umbilical arteries of the placenta (Figure 4(a)). A signiﬁcant proportion of
HPCs, including highly proliferative potential colony forming cells (HPP-CFCs), are detected in the mouse
placenta [25]. HSCs (c-Kit+/CD34+) by 11.5dpc, and the number increase until 12.5dpc, resulting in a 15-
fold increase in HSC activity compared with that of the AGM region [26, 27]. These ﬁndings indicate that
mouse PL is a likely site for HSC generation and expansion at mid-gestation. Formation of HC clusters in
both the AGM region and PL is impaired in mutant mice deﬁcient in genes encoding speciﬁc transcription
factors, namely, Runx1, Evi-1, and c-Myb, suggesting the importance of intrinsic regulation [7, 20, 28, 29].
Relevant to extrinsic regulation of PL HSCs, IL-3 not only is a target of Runx1 in adult HCs, but also
regulates HSC proliferation in the PL [30]. We previously demonstrated regulation of HC clusters in the
PL by surrounding niche cells [23]. To do so, we used laser-capture microdissection and ﬂow cytometry
to capture niche cells. Among several cytokine genes, only SCF was expressed in niche cells, particularly
in ECs. SCF protein expression was conﬁrmed by ELISA and immunohistochemistry. Administration of
blocking antibodies to c-Kit, the SCF receptor, clearly demonstrated that SCF/c-Kit signaling is pivotal for
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FIGURE 3: Hematopoietic environment in the AGM region. (a) (upper) Model of HC clusters, which are
attached to the endothelial wall mainly on the ventral side. (lower) Confocal images of an HC cluster ex-
pressing CD34/c-Kit in the aortic region at 10.5dpc. AGM region tissue sections were prepared from ICR
mouse embryos at 10.5dpc, stained with antibodies, and observed under confocal microscopy. CD34 (red),
c-Kit (green), and TOTO-3 (blue). (b) Model of intrinsic and extrinsic regulation at the AGM region. (upper)
Transcription factors (such as Runx1) maintain HSC development as intrinsic regulators. Signal transducers
(such as Ptch and Smo) and transcription factor (such as Gli1, 2, 3) in mesenchymal cells maintain HSC
number and development. (lower) Cytokines (SCF and IL-1) maintain HC clusters and HSC development
as extrinsic regulators.
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FIGURE 4: Hematopoietic environment in the placenta. (a) (upper) Model of HC clusters in the placenta.
HC clusters are attached to the endothelial wall of capillary vessels, the so-called vascular labyrinth region,
from 10.5dpc to 12.5dpc. (lower) Confocal images of an HC cluster expressing CD31/c-Kit in the placenta at
10.5dpc. Sections of placenta were prepared from ICR mouse embryos at 10.5dpc, stained with indicated
antibodies and observed under confocal microscopy. CD31 (red), Kit (green), and TOTO-3 (blue). (b) Model
of intrinsic and extrinsic regulation in the placenta. (upper) Transcription factors (such as Runx1, Evi-1, c-
Myb) maintain HSC development intrinsically. (lower) Cytokines (such as SCF and IL-3) maintain HSCs as
extrinsic regulators.
HSC regulation in the PL [23]( Figure 4(b)). Based on gene expression analysis, niche cells do not express
IL-3 [23], although future studies are required to clarify its function in vivo.
5. FETAL LIVER
Hematopoiesis occurs in fetal liver (FL) by mid-gestation [31–33]. After HSCs are generated in the YS,
AGM region, and PL, they migrate into FL, where HSCs are maintained and the number of HSCs dramat-
ically increasesbetween 12 and 16dpc, during which time differentiation of mature HCs, particularly eryth-
rocytes, occurs [32–34]. Thus FL is an organ appropriate for investigation of HSC expansion and eryth-
ropoiesis in vitro. FL HSCs express the markers c-Kit, stem cell antigen-1 (Sca-1), and protein tyrosine
phosphatase, receptor type, C (CD45, also known as common leukocyte antigen). Circulating HPCs and
HSCs expressing c-Kit have been reported to colonize FL [35]. Both morphological observation and
experiments in vitro suggest that FL itself does not produce HSCs or HPCs but may be colonized by HCs
of extrinsic origin after 9.5dpc [32, 33, 36, 37]. Intrinsic regulation of hematopoiesis in FL has also been
reported. Factors that function in that activity include PU.1, an ETS family transcription factor, which
functions in maintenance (differentiation) or expansion of FL HSCs [38]. Class I Hoxb4 and Hoxb3 also
positively regulate HSC and HPC proliferation by accelerating the cell cycle [39]. Cited2 (a CBP/p300-
interacting transactivator with a glutamic acid [E] and aspartic acid [D]-rich tail 2) maintains FL HSCs and
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FIGURE 5: Hematopoietic environment in fetal liver. (a) (upper) Structure of fetal liver, which primarily con-
sists of hematopoietic cells, sinusoid endothelial cells, and hepatoblasts. (lower) Confocal images of FL
expressing Dlk-1/c-Kit (Right). FL sections were prepared from ICR mouse embryos at 12.5dpc, stained
with indicated antibodies, and observed by confocal microscopy. c-Kit (green), Dlk-1 (red), and TOTO-3
(blue). (b) Intrinsic and extrinsic regulation in FL. (upper) Transcription factors (speciﬁcally, PU.1, Hoxb3,
and Hoxb4) and cytokines (such as SCF and EPO) play important roles in HSC expansion and differentiation
in FL. (lower) Liver sections were prepared from ICR mouse embryos at 12.5dpc and stained with Dlk-1
(green), EPO (red) and TOTO-3 (blue) (Left), and Dlk-1 (green), SCF (red), and TOTO-3 (blue) (Right).
HPCs [40]. Relevant to extrinsic regulation of FL hematopoiesis, FL consists of hepatoblasts (hepatocyte
precursors), ECs, hematopoietic cells [41, 42], and other cells such as MCs (Figure 5(a)). Among them,
we recently demonstrated that hepatoblasts expressing Dlk-1 function in HSC differentiation, particularly
erythropoiesis, through secretion of erythropoietin (EPO), a cytokine regulating erythroid differentiation
and SCF [43]( Figure 5(b)). In addition, hepatoblasts (SCF+DLK+) function at 15.5dpc in FL to increase
the number of HSCs likely through production of several cytokines, angiopoietin-like 3 (Angptl3), insulin-
like growth factor-2 (IGF2), SCF, and thrombopoietin (TPO) [44]. Taken together, hepatoblasts comprise a
niche for HSC regulation through cytokine secretion. However, it remains unclearhow HSCs maintain self-
renewalcapacityunderintenseexposuretocytokines,whichstimulateHSCdifferentiation.Also,in addition
to cytokines, the extracellular matrix (ECM), including the interstitial matrix and basement membrane, in-
teracts with cell surface receptors to regulate hematopoiesisextrinsically in FL. Integrins, which function as
receptors for ECM, are important effectors of cell adhesion, differentiation, and migration. Particularly in
FL hematopoiesis, beta-1 integrin (ﬁbronectin receptor, CD29) is reportedly crucial for HSC colonization
[45–48]. Interaction of integrin heterodimers with ECMs could function as a homing mechanismand enable
HSCs and hematopoietic progenitor cells (HPCs) to reside in FL [49–51]. ECM proteins are produced in
various cell types and interact with cytokines, enabling cells to interpret cytokine signaling in a particular
context [52].
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6. FETAL SPLEEN AND BONE MARROW
After the number of HSCs increases in the FL, those cells home to fetal-spleen, where HSCs differentiate
at 13.5 to 14.5dpc [53]. Fetal spleen-derived stromal cells enable HSCs to differentiate primarily into
macrophages(F4/80+Mac1+) rather than lymphocytes.After transient hematopoiesisin fetal spleen, HSCs
gradually home to BM after 16.5dpc, where they remain during their entire lifetime. Although fetal BM
is formed by 15.5dpc, HSCs capable of self-renewal and which are positive for the signaling lymphocyte
activation molecule (SLAM) family marker CD150 and negative for CD48 and CD41 cannot be detected
in this tissue until 17.5dpc, suggesting that other mechanisms govern the ability of HSCs to home to fetal
BM during this period. Expression of genes encoding HSC migration factors, such as Cxcr4 (a chemokine
receptor), Col4a1 (related to type IV collagen alpha1 synthesis), Mmp2, Timp2 (related to degradation and
regulation of development), is signiﬁcantly upregulated in HSCs during embryonic development [54].
7. CONCLUDING REMARKS
During embryogenesis, extrinsic regulation by niche cells is pivotal for HSC generation, expansion, dif-
ferentiation, and maintenance. Increased knowledge of niche cell regulation should facilitate development
of novel methods of in vitro generation, expansion, and differentiation for HSCs. Furthermore, if artiﬁcial
niche components that replicate internal environment in vivo could maintain the status of stem cell, for
example, cell cycle and quiescence, migration of both normal HSCs and leukemic stem cells might be
directed as planned.Thestudy of nicheregulation of hematopoiesisshould impactnovelstem cell engineer-
ing, which could be applied for clinical therapies in the future.
ABBREVIATIONS
dpc: Days post coitum
YS: Yolk sac
BI: Blood island
AGM: Aorta-gonad-mesonephros
PL: Placenta
FL: Fetal liver
BM: Bone marrow
HSC: Hematopoietic stem cell
HPC: Hematopoietic progenitor cell
HC: Hematopoietic cell.
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